In a transgene-induced endogenous mammary tumor model, GRP78 haploinsufficiency resulted in delayed tumor latency, decreased tumor proliferation, and increased apoptosis (Wang et al., 2010). The gene discussed is HSPA5; the disease is breast cancer.